Skip to content

Prospective assessment of periarticular Injection of liposomal bupivacaine versus ropivacaine for pain control in combination with adductor canal block in total knee arthroplasty: A randomized,double-blind, controlled study

Prospective assessment of periarticular Injection of liposomal bupivacaine versus ropivacaine for pain control in combination with adductor canal block in total knee arthroplasty: A randomized,double-blind, controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094329
Enrollment
Unknown
Registered
2024-12-20
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia after TKA

Interventions

Test group (bupivacaine liposome protocol):Bupivacaine liposomal for adductor canal block and periarticular infiltrate
Control group (Ropivacaine group): Ropivacaine for adductor canal block and periarticular infiltrate

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing initial unilateral total knee replacement for osteoarthritis of the knee; 2.Age: 18 to 80 years old. 3. BMI: 18-28 kg/m^2; 4.American Society of Anesthesiologists (ASA) class I to III; 5. Willing to sign informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with bilateral, revision knee replacements; 2.Patients with non-osteoarthritis, such as rheumatoid arthritis and traumatic arthritis; 3. Patients who are allergic to various anaesthetic drugs; 4. Abnormal blood clotting time and platelet count; 5.Pre-operative presence of cognitive dysfunction; 6.Unwilling to sign informed consent.

Design outcomes

Secondary

MeasureTime frame
Opioids consumption;Length of hospital stay;Sleep quality;Joint mobility;Drug adverse reaction(Cardiac toxicity);Functional evaluation of the knee;VAS pain score of exercise at other time points postoperatively;Drug cost;

Primary

MeasureTime frame
VAS pain score of exercise on 48 h postoperatively;

Countries

China

Contacts

Public ContactYunchao Shao

Zhongshan Hospital, Fudan University

shao.yunchao@163.com+86 139 1632 3753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026